Key Market Indicators
Costa Rican antihypertensive medicine sales are on the rise. In 2021, they reached $1.8 million, up 9% since 2012. Italy, Spain and Australia respectively were the top three markets in 2021, with Estonia taking the fourth spot at $1.5 million. It is expected that sales will continue to increase, reaching $1.8 million by 2026.
